Cargando…

Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry

The Covid-19 pandemic has affected the global population since 2019. The rapid development and approval of vaccines has brought relief. Yet, effective cures are still being researched. Even if the pandemic situation may end, SARS-CoV-2 will remain and, thus, continued application of the drugs will l...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartels, Indra, Jaeger, Martin, Schmidt, Torsten C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444687/
https://www.ncbi.nlm.nih.gov/pubmed/37439856
http://dx.doi.org/10.1007/s00216-023-04811-7
_version_ 1785094004290879488
author Bartels, Indra
Jaeger, Martin
Schmidt, Torsten C.
author_facet Bartels, Indra
Jaeger, Martin
Schmidt, Torsten C.
author_sort Bartels, Indra
collection PubMed
description The Covid-19 pandemic has affected the global population since 2019. The rapid development and approval of vaccines has brought relief. Yet, effective cures are still being researched. Even if the pandemic situation may end, SARS-CoV-2 will remain and, thus, continued application of the drugs will lead to emissions of the active ingredients into the aquatic environment, as with other anthropogenic micropollutants. However, a general method for trace analysis of antiviral drugs is still missing. To this purpose, favipiravir, remdesivir, its active metabolite GS-441524, molnupiravir and its active metabolite EIDD-1931 were selected as representative analytes. A method was developed based on solid phase extraction and high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight high-resolution mass spectrometry. Optimization comprised the choice of chromatographic columns, elution gradient, mass spectrometry and tandem mass spectrometry parameters. Solid phase extraction proved suitable for increase in limits of detection and quantitation. amelioration of the limits of detection and quantitation. Matrix effects were investigated applying the optimized method to a wastewater sample with added virustatics. All five compounds could be separated with reversed phase chromatography, whereas EIDD-1931 profited from hydrophilic interaction liquid chromatography. The optimized method yielded limits of detection and quantification of 2.1·10(-1), 6.9·10(-1) µg·L(-1) for favipiravir, 1.8·10(-3), 5.5·10(-3) µg·L(-1) for remdesivir, 1.9·10(-3), 7.6·10(-3) µg·L(-1) for GS-441524, 2.9·10(-3), 8.7·10(-3) µg·L(-1) for molnupiravir, and 1.3·10(-1), 3.8·10(-1) µg·L(-1) for EIDD 1931. The method was first applied to compound stability testing at pH 2.8 and 9.7. At pH 2.8, remdesivir, GS-441524 and molnupiravir proved stable, whereas about 14% of EIDD-1931 and favipiravir were degraded. All five antiviral compounds were almost completely decomposed at pH 9.7. The application of the method was further demonstrated for potential transformation product detection on favipiravir ozonation monitoring. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-023-04811-7.
format Online
Article
Text
id pubmed-10444687
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104446872023-08-24 Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry Bartels, Indra Jaeger, Martin Schmidt, Torsten C. Anal Bioanal Chem Research Paper The Covid-19 pandemic has affected the global population since 2019. The rapid development and approval of vaccines has brought relief. Yet, effective cures are still being researched. Even if the pandemic situation may end, SARS-CoV-2 will remain and, thus, continued application of the drugs will lead to emissions of the active ingredients into the aquatic environment, as with other anthropogenic micropollutants. However, a general method for trace analysis of antiviral drugs is still missing. To this purpose, favipiravir, remdesivir, its active metabolite GS-441524, molnupiravir and its active metabolite EIDD-1931 were selected as representative analytes. A method was developed based on solid phase extraction and high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight high-resolution mass spectrometry. Optimization comprised the choice of chromatographic columns, elution gradient, mass spectrometry and tandem mass spectrometry parameters. Solid phase extraction proved suitable for increase in limits of detection and quantitation. amelioration of the limits of detection and quantitation. Matrix effects were investigated applying the optimized method to a wastewater sample with added virustatics. All five compounds could be separated with reversed phase chromatography, whereas EIDD-1931 profited from hydrophilic interaction liquid chromatography. The optimized method yielded limits of detection and quantification of 2.1·10(-1), 6.9·10(-1) µg·L(-1) for favipiravir, 1.8·10(-3), 5.5·10(-3) µg·L(-1) for remdesivir, 1.9·10(-3), 7.6·10(-3) µg·L(-1) for GS-441524, 2.9·10(-3), 8.7·10(-3) µg·L(-1) for molnupiravir, and 1.3·10(-1), 3.8·10(-1) µg·L(-1) for EIDD 1931. The method was first applied to compound stability testing at pH 2.8 and 9.7. At pH 2.8, remdesivir, GS-441524 and molnupiravir proved stable, whereas about 14% of EIDD-1931 and favipiravir were degraded. All five antiviral compounds were almost completely decomposed at pH 9.7. The application of the method was further demonstrated for potential transformation product detection on favipiravir ozonation monitoring. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-023-04811-7. Springer Berlin Heidelberg 2023-07-13 2023 /pmc/articles/PMC10444687/ /pubmed/37439856 http://dx.doi.org/10.1007/s00216-023-04811-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Paper
Bartels, Indra
Jaeger, Martin
Schmidt, Torsten C.
Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry
title Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry
title_full Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry
title_fullStr Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry
title_full_unstemmed Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry
title_short Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry
title_sort determination of anti-sars-cov-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444687/
https://www.ncbi.nlm.nih.gov/pubmed/37439856
http://dx.doi.org/10.1007/s00216-023-04811-7
work_keys_str_mv AT bartelsindra determinationofantisarscov2virustaticpharmaceuticalsintheaquaticenvironmentusinghighperformanceliquidchromatographyhighresolutionmassspectrometry
AT jaegermartin determinationofantisarscov2virustaticpharmaceuticalsintheaquaticenvironmentusinghighperformanceliquidchromatographyhighresolutionmassspectrometry
AT schmidttorstenc determinationofantisarscov2virustaticpharmaceuticalsintheaquaticenvironmentusinghighperformanceliquidchromatographyhighresolutionmassspectrometry